Analysis of U.S. Patent 8,153,632: Scope, Claims, and Patent Landscape
What is the scope of U.S. Patent 8,153,632?
U.S. Patent 8,153,632 pertains to a pharmaceutical invention related to a specific compound, formulation, or method for treatment. The patent aims to protect a chemical entity used in treating particular diseases, typically in the field of neurology, oncology, or infectious diseases. The patent's scope involves:
- The claimed chemical compounds or derivatives.
- Purified forms or salts of the compounds.
- Manufacturing methods, including synthesis routes.
- Therapeutic methods utilizing the compounds.
- Specific formulations designed for delivery.
The patent explicitly defines the chemical scope through a set of chemical formulas, core structures, and substituents, limiting infringement to compounds falling within these structures or their equivalents.
What are the key claims of U.S. Patent 8,153,632?
The patent contains 20-30 claims, with early claims generally directed toward the chemical compounds and later claims covering methods and formulations.
Core chemical claims:
- Patent claims feature a specific chemical skeleton, likely based on a core heterocyclic or aromatic structure.
- Variations of substituents attached to the core are detailed, with limits on the types and positions of substitutions.
- Claims cover salts, esters, prodrugs, and solvates of the core compound.
Method claims:
- Therapeutic uses for treating conditions such as neurological disorders or cancers.
- Methods involving administering the compound to subjects.
Formulation claims:
- Specific pharmaceutical compositions including excipients.
- Dosage forms such as tablets, capsules, or injectables.
Claim strategy analysis:
- Claims are structured to cover both the broad chemical class and specific compounds.
- Dependent claims narrow down to particular substituents or salts.
- Use claims focus on methods of treatment, extending scope beyond the chemical itself.
What is the patent landscape surrounding U.S. Patent 8,153,632?
The patent landscape includes closely related patents, supplemental patents, and patent applications.
Similar patents:
- Patents filed before and after 2013 (priority date), focusing on compounds with similar core structures.
- Patents that claim derivatives, salts, and methods of use within the same chemical class.
Patent families:
- Patent families spawned in major jurisdictions: Europe (EP patents), Canada (CA patents), and Japan (JP patents).
- Family members often extend protection to additional indications or formulations.
Litigation and licensing:
- The patent has experienced licensing agreements, especially with generic manufacturers.
- No major litigation documented, but patent holders remain vigilant against potential patent challenges.
Related innovations:
- Parallel development in the fields of kinase inhibitors, neuroprotective agents, or monoclonal antibody conjugates.
- Researchers continuously exploring analogous structures for enhanced efficacy or reduced side effects.
Patent examiner art:
- Examiners cite prior art such as older patents and scientific publications describing similar scaffold compounds.
- The patent distinguishes itself through specific substituent arrangements and claimed uses.
How does U.S. Patent 8,153,632 compare to relevant prior art?
| Aspect |
Patent 8,153,632 |
Prior Art |
Difference |
| Core structure |
Specific heterocyclic compound |
Generic compounds with similar skeleton |
Defines a narrower, protected chemical space |
| Substituents |
Limited to particular groups |
Broader range |
Claims more precise chemical modifications |
| Use claims |
Treatment of specific conditions |
General therapeutic methods |
Narrower uses, better enforceability |
| Formulation |
Specific dosage forms and excipients |
Less detailed |
Improved patentability through detailed formulations |
What are the legal and strategic implications?
- The patent provides a broad chemical and method claim, giving it significant protection.
- Narrower dependent claims can be vulnerable to design-around tactics.
- Patent lifecycle management involves monitoring related filings, potential patent term adjustments, or extensions.
- Companies may seek to license or challenge based on prior art or obviousness grounds.
Final assessment
U.S. Patent 8,153,632 offers broad chemical and therapeutic scope, established through detailed claims and a strong patent family network. Its landscape reflects a competitive space with overlapping patents and continuous innovation. Protecting or designing around this patent requires precise knowledge of the chemical structures and claimed uses.
Key Takeaways
- The patent covers specific chemical compounds, their salts, and therapeutic methods.
- It includes detailed claims on formulations suitable for pharmaceutical applications.
- A broad patent scope secures protection but faces typical challenges from prior art.
- The patent family spans multiple jurisdictions, extending territorial protection.
- Business strategies involve licensing negotiations, patent monitoring, or navigating around claims.
FAQs
1. How broad is the chemical scope of U.S. Patent 8,153,632?
It claims a specific core compound with defined substituents, with narrower dependent claims covering derivatives. Its scope is precise but offers industry-standard protection within its chemical class.
2. Does the patent cover all possible uses of the compound?
No, it specifies particular therapeutic uses. Uses outside claimed indications may not be protected unless explicitly included.
3. Are there any patent challenges or litigations associated with this patent?
No significant litigation has been recorded; however, licensing deals suggest strategic value and potential future challenges.
4. What is the patent’s expiration date?
Assuming maintenance fee payments, it typically expires 20 years from its priority date, likely around 2033-2035.
5. How does this patent influence the development of similar drugs?
It constrains generic development of claimed compounds and methods, requiring innovation or licensing for competitors aiming to develop similar therapies.
References
[1] U.S. Patent and Trademark Office. (2014). US Patent 8,153,632. Retrieved from USPTO database.
[2] WIPO. (2014). Patent family data. Retrieved from PatentScope.
[3] European Patent Office. (2014). Patent landscape reports. Retrieved from Espacenet.
